Scholarlink

<p>Antimicrobial resistance (AMR) in pathogens such as multidrug-resistant <i>Salmonella</i> Typhimurium and extended-spectrum β-lactamase (ESBL) <i>Escherichia coli</i> poses a growing threat to human, animal, and environmental health, yet effective non-antibiotic mitigation strategies remain limited. Here, we report the isolation and comprehensive characterization of three lactic acid bacteria from homemade cottage cheese, including <i>Leuconostoc pseudomesenteroides</i> MLS3, <i>Lactococcus lactis</i> MLS12, and <i>Leuconostoc lactis</i> MLS22 as next-generation probiotic candidates targeting these AMR pathogens. Whole-genome sequencing confirmed compact genomes (1.7–2.5&#xa0;Mb) free of transferable resistance determinants and enriched in secondary metabolite biosynthetic clusters. All three strains survived gastrointestinal challenge conditions (≥ 6 log CFU/mL at pH 1.5, 2% bile salts, and 100&#xa0;µg/mL lysozyme), exhibited strong mucosal adhesion parameters (auto-aggregation 30–33%, surface hydrophobicity 20–49%), and co-aggregated efficiently with both pathogens (27–64%). Live co-cultures and cell-free supernatants significantly inhibited <i>S.</i> Typhimurium and ESBL <i>E. coli</i> within 24&#xa0;h, with electron microscopy revealing probiotic-induced structural disruption of pathogen cell integrity. Probiotic pretreatment extended <i>Caenorhabditis elegans</i> lifespan under <i>Salmonella</i> challenge (<i>P</i> &lt; 0.001), and cell-free supernatants attenuated LPS-induced epithelial barrier permeability in chicken enteroids (<i>P</i> &lt; 0.05) without affecting baseline barrier function. Together, these findings demonstrate that MLS3, MLS12, and MLS22 combine genomic safety, gastrointestinal resilience, direct antimicrobial potency, and epithelial barrier protection, supporting their potential as effective probiotics for AMR-associated applications in food safety and gut health.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Isolation and characterization of probiotic candidates with antimicrobial and barrier-protective properties

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月3日

查看全文
  • Jiddu Joseph,
  • Sanya Boby,
  • Zhaoyan Zhu,
  • Shankumar Mooyottu,
  • Poonam Gopika Vinayamohan,
  • Abraham Joseph Pellissery,
  • Yihang Li,
  • Muhammed Shafeekh Muyyarikkandy

摘要

Antimicrobial resistance (AMR) in pathogens such as multidrug-resistant Salmonella Typhimurium and extended-spectrum β-lactamase (ESBL) Escherichia coli poses a growing threat to human, animal, and environmental health, yet effective non-antibiotic mitigation strategies remain limited. Here, we report the isolation and comprehensive characterization of three lactic acid bacteria from homemade cottage cheese, including Leuconostoc pseudomesenteroides MLS3, Lactococcus lactis MLS12, and Leuconostoc lactis MLS22 as next-generation probiotic candidates targeting these AMR pathogens. Whole-genome sequencing confirmed compact genomes (1.7–2.5 Mb) free of transferable resistance determinants and enriched in secondary metabolite biosynthetic clusters. All three strains survived gastrointestinal challenge conditions (≥ 6 log CFU/mL at pH 1.5, 2% bile salts, and 100 µg/mL lysozyme), exhibited strong mucosal adhesion parameters (auto-aggregation 30–33%, surface hydrophobicity 20–49%), and co-aggregated efficiently with both pathogens (27–64%). Live co-cultures and cell-free supernatants significantly inhibited S. Typhimurium and ESBL E. coli within 24 h, with electron microscopy revealing probiotic-induced structural disruption of pathogen cell integrity. Probiotic pretreatment extended Caenorhabditis elegans lifespan under Salmonella challenge (P < 0.001), and cell-free supernatants attenuated LPS-induced epithelial barrier permeability in chicken enteroids (P < 0.05) without affecting baseline barrier function. Together, these findings demonstrate that MLS3, MLS12, and MLS22 combine genomic safety, gastrointestinal resilience, direct antimicrobial potency, and epithelial barrier protection, supporting their potential as effective probiotics for AMR-associated applications in food safety and gut health.